GRAND RAPIDS, MI – Spectrum health doctors recently completed their 200th procedure using robotic technology to diagnose early-stage lung cancer, officials said.
The integrated health system’s use of a robotic bronchoscopy platform has diagnosed 20% more cases, according to an Oct. 12 press release. This improves patient outcomes by providing access to earlier treatment options with more precision.
Two years ago, Spectrum Health launched Auris Health’s Monarch platform, an innovative endoscopy tool. More recently, doctors have combined this with Phillips’ Cone Beam CT technology and augmented fluoroscopy to help diagnose with great precision.
“We are equipped with the two leading technologies on the market. By combining these two highly innovative technologies, it will allow us to reach any area of concern with unprecedented precision, ”said Dr Gustavo Cumbo-Nacheli, Director of Bronchoscopy and Interventional Pulmonary Medicine for Spectrum Health.
“Soon we will have the ability not only to diagnose a suspicious lesion, but also to treat these lung nodules in the same procedure. This revolutionary technology is designed to enable physicians to diagnose small peripheral lung nodules with high accuracy, using advanced imaging with a less invasive approach, providing a better experience for our patients. “
While Metro Health at the University of Michigan uses similar technology, there are key differentiators that set Spectrum Health apart, explains Cumbo-Nacheli.
Metro Health’s Ion robotic catheter, like the Monarch used by Spectrum Health, allows a doctor to reach deeper into the lungs with control. However, the monarch provides uninterrupted vision to the doctor, which leaves less room for error. The Ion does not have this functionality.
The combined technologies of the Monarch and Cone Beam CT allow physicians to analyze a 360-degree, three-dimensional image of a nodule, providing the patient with the most accurate diagnosis and treatment plan.
Doctors say they are seeing great results with new treatment plans for the 200 patients who have undergone the procedure so far.
The platform directs a flexible robotic endoscope deep into the lungs, accurately guiding an instrument even through the most difficult nodules. It does this while maintaining vision during the most critical segment of the procedure, the biopsy.
While there are currently a variety of diagnostic options available for lung conditions, this new platform has the ability to improve accuracy and safety in a less invasive way, according to the press release. The robot allows more precision than possible with other technologies.
“Our robot is the only one in West Michigan that allows us to maintain vision throughout the procedure, while the Cone Beam CT allows precise placement of our instruments,” said Dr. John P Egan III, interventional pulmonologist. for Spectrum Health.
“This technology, combined with lung cancer screening and better smoking cessation programs, will help us continue to turn the tide against the country’s deadliest cancer. “
Officials say Drs. Cumbo-Nacheli and Egan’s experience with combined technologies established them as national leaders, helping to mentor other health systems, form high-level partnerships to improve technology, and attract patients from all over the world. Michigan.
More on MLive: